NISA INVESTMENT ADVISORS, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1
-100.0%
400
+86.9%
0.00%
Q2 2022$4,000
-33.3%
2140.0%0.00%
Q1 2022$6,000
-93.5%
214
-95.8%
0.00%
-100.0%
Q4 2021$93,000
-19.8%
5,077
+14.7%
0.00%0.0%
Q3 2021$116,000
-25.6%
4,426
-9.4%
0.00%0.0%
Q2 2021$156,000
-9.3%
4,8840.0%0.00%0.0%
Q1 2021$172,000
+9.6%
4,8840.0%0.00%0.0%
Q4 2020$157,0004,8840.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders